SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Irina Kirpich, Matthew Miller, Matthew Cave, Swati Joshi-Barve, Craig McClain, Alcoholic Liver Disease: Update on the Role of Dietary Fat, Biomolecules, 2016, 6, 1, 1

    CrossRef

  2. 2
    M. Rahman Alizadeh, A. H. Mahdavi, H. R. Rahmani, E. Jahanian, Clove bud (Syzygium aromaticum) improved blood and hepatic antioxidant indices in laying hens receiving low n-6 to n-3 ratios, Journal of Animal Physiology and Animal Nutrition, 2016, 100, 2
  3. 3
    Swaytha Ganesh, Vinod K. Rustgi, Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2016, 20, 2, 351

    CrossRef

  4. 4
    Yuriko Adkins, Dawn M. Fedor, Bruce E. Mackey, Jian Wu, Darshan S. Kelley, Dietary docosahexaenoic acid reverses nonalcoholic steatohepatitis and fibrosis caused by conjugated linoleic acid supplementation in mice, Journal of Functional Foods, 2016, 20, 443

    CrossRef

  5. 5
    Yasue HOSOYAMADA, Masako YAMADA, Effects of Dietary Fish Oil on the Oxidative Stress in Obese Zucker Rats, Japanese Journal of Complementary and Alternative Medicine, 2016, 13, 1, 13

    CrossRef

  6. 6
    Yuzuru Iizuka, Hyounju Kim, Maki Nakasatomi, Takuya Izawa, Satoshi Hirako, Akiyo Matsumoto, Fish oil prevents excessive accumulation of subcutaneous fat caused by an adverse effect of pioglitazone treatment and positively changes adipocytes in KK mice, Toxicology Reports, 2016, 3, 4

    CrossRef

  7. 7
    Donald B. Jump, Christopher M. Depner, Sasmita Tripathy, Kelli A. Lytle, Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice, Proceedings of the Nutrition Society, 2016, 75, 01, 1

    CrossRef

  8. 8
    T. O. Freire, R. S. S. B. Boulhosa, L. P. M. Oliveira, R. P. Jesus, L. N. Cavalcante, D. C. Lemaire, M. B. P. Toralles, L. G. C. Lyra, A. C. Lyra, n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial, Journal of Human Nutrition and Dietetics, 2016, 29, 3
  9. 9
    Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti, Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease, Journal of Diabetes Research, 2016, 2016, 1

    CrossRef

  10. 10
    Paola Dongiovanni, Claudia Lanti, Patrizia Riso, Luca Valenti, Nutritional therapy for nonalcoholic fatty liver disease, The Journal of Nutritional Biochemistry, 2016, 29, 1

    CrossRef

  11. 11
    Valerio Nobili, Anna Alisi, Giovanni Musso, Eleonora Scorletti, Philip C. Calder, Christopher D. Byrne, Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD, Critical Reviews in Clinical Laboratory Sciences, 2016, 53, 2, 106

    CrossRef

  12. 12
    Monize Aydar Nogueira, Claudia Pinto Oliveira, Venâncio Avancini Ferreira Alves, José Tadeu Stefano, Lívia Samara dos Reis Rodrigues, Raquel Susana Torrinhas, Bruno Cogliati, Hermes Barbeiro, Flair José Carrilho, Dan Linetzky Waitzberg, Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial, Clinical Nutrition, 2016, 35, 3, 578

    CrossRef

  13. 13
    Morihiro Matsuda, Toshiharu Kawamoto, Ritsu Tamura, Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis, Obesity Research & Clinical Practice, 2016,

    CrossRef

  14. 14
    J. A. Woo Baidal, J. E. Lavine, The intersection of nonalcoholic fatty liver disease and obesity, Science Translational Medicine, 2016, 8, 323, 323rv1

    CrossRef

  15. 15
    Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Amedeo Lonardo, The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans, Advances in Therapy, 2016, 33, 3, 291

    CrossRef

  16. 16
    Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Reham Kamel Farahat, Manal El-Hamamsy, ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study, Nutrition, 2016, 32, 1, 41

    CrossRef

  17. 17
    Philippa Gibson, Sarah Lang, Marianne Gilbert, Deepa Kamat, Sanjay Bansal, Martha Ford-Adams, Ashish Desai, Anil Dhawan, Emer Fitzpatrick, J. Moore, Kathryn Hart, Assessment of Diet and Physical Activity in Paediatric Non-Alcoholic Fatty Liver Disease Patients: A United Kingdom Case Control Study, Nutrients, 2015, 7, 12, 9721

    CrossRef

  18. 18
    Chao-Qun Yang, Long Shu, Shuai Wang, Jia-Jia Wang, Yu Zhou, Yu-Jie Xuan, Su-Fang Wang, Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults, Nutrients, 2015, 7, 6, 4778

    CrossRef

  19. 19
    Michael Kruse, Christian von Loeffelholz, Daniela Hoffmann, Antje Pohlmann, Anne-Cathrin Seltmann, Martin Osterhoff, Silke Hornemann, Olga Pivovarova, Sascha Rohn, Gerhard Jahreis, Andreas F. H. Pfeiffer, Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men, Molecular Nutrition & Food Research, 2015, 59, 3
  20. 20
    Srinivasan Dasarathy, Jaividhya Dasarathy, Amer Khiyami, Lisa Yerian, Carol Hawkins, Ruth Sargent, Arthur J. McCullough, Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis, Journal of Clinical Gastroenterology, 2015, 49, 2, 137

    CrossRef

  21. 21
    N. U. Ashraf, T. A. Sheikh, Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease, Free Radical Research, 2015, 49, 12, 1405

    CrossRef

  22. 22
    Libo Wang, Shaminie Athinarayanan, Guanglong Jiang, Naga Chalasani, Min Zhang, Wanqing Liu, Fattyaciddesaturase 1 gene polymorphisms control human hepatic lipid composition, Hepatology, 2015, 61, 1
  23. 23
    Jonathan Merola, AnnMarie Liapakis, David C. Mulligan, Peter S. Yoo, Non-alcoholic fatty liver disease following liver transplantation: a clinical review, Clinical Transplantation, 2015, 29, 9
  24. 24
    Wojciech Janczyk, Dariusz Lebensztejn, Aldona Wierzbicka-Rucińska, Artur Mazur, Joanna Neuhoff-Murawska, Paweł Matusik, Piotr Socha, Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial, The Journal of Pediatrics, 2015, 166, 6, 1358

    CrossRef

  25. 25
    S. Spahis, F. Alvarez, J. Dubois, N. Ahmed, N. Peretti, E. Levy, Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2015, 99, 25

    CrossRef

  26. 26
    Fabien Wauquier, Laurent Léotoing, Claire Philippe, Mélanie Spilmont, Véronique Coxam, Yohann Wittrant, Pros and cons of fatty acids in bone biology, Progress in Lipid Research, 2015, 58, 121

    CrossRef

  27. 27
    S. Gitto, G. Vitale, E. Villa, P. Andreone, Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future, Gastroenterology Research and Practice, 2015, 2015, 1

    CrossRef

  28. 28
    Jung Mi Han, An Na Jo, Seung Min Lee, Hyun Suk Bae, Dae Won Jun, Yong Kyun Cho, Ki Tae Suk, Jai Hoon Yoon, Sang Bong Ahn, Yong Jin Cho, Seong Woo Kim, Eun Chul Jang, Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults, Journal of Gastroenterology and Hepatology, 2014, 29, 6
  29. 29
    E. Scorletti, L. Bhatia, K.G. McCormick, G.F. Clough, K. Nash, P.C. Calder, C.D. Byrne, Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease, Contemporary Clinical Trials, 2014, 37, 2, 301

    CrossRef

  30. 30
    Ali Hashemi Kani, Seyed Moayed Alavian, Fahimeh Haghighatdoost, Leila Azadbakht, Diet Macronutrients Composition in Nonalcoholic Fatty Liver Disease: A Review on the Related Documents, Hepatitis Monthly, 2014, 14, 2

    CrossRef

  31. 31
    Mohamed Asrih, François R. Jornayvaz, Diets and nonalcoholic fatty liver disease: The good and the bad, Clinical Nutrition, 2014, 33, 2, 186

    CrossRef

  32. 32
    Priyanka Nigam, Suryaprakash Bhatt, Anoop Misra, Davinder S. Chadha, Meera Vaidya, Jharna Dasgupta, Qadar M.A. Pasha, Effect of a 6-Month Intervention with Cooking Oils Containing a High Concentration of Monounsaturated Fatty Acids (Olive and Canola Oils) Compared with Control Oil in Male Asian Indians with Nonalcoholic Fatty Liver Disease, Diabetes Technology & Therapeutics, 2014, 16, 4, 255

    CrossRef

  33. 33
    Thereza C. Lonzetti Bargut, Eliete D. C. Frantz, Carlos A. Mandarim-de-Lacerda, Marcia Barbosa Aguila, Effects of a Diet Rich in n-3 Polyunsaturated Fatty Acids on Hepatic Lipogenesis and Beta-Oxidation in Mice, Lipids, 2014, 49, 5, 431

    CrossRef

  34. 34
    Eleonora Scorletti, Lokpal Bhatia, Keith G. McCormick, Geraldine F. Clough, Kathryn Nash, Leanne Hodson, Helen E. Moyses, Philip C. Calder, Christopher D. Byrne, Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study, Hepatology, 2014, 60, 4
  35. 35
    Hsin-Yu Lin, Chih-Chien Chen, Yu-Jen Chen, Yuan-Yu Lin, Harry J. Mersmann, Shih-Torng Ding, Enhanced Amelioration of High-Fat Diet-Induced Fatty Liver by Docosahexaenoic Acid and Lysine Supplementations, BioMed Research International, 2014, 2014, 1

    CrossRef

  36. 36
    Morag F Dick, Jennifer Hurford, Sha Lei, Anne-Mari Mustonen, Petteri Nieminen, Kirsti Rouvinen-Watt, High feeding intensity increases the severity of fatty liver in the American mink (Neovison vison) with potential ameliorating role for long-chain n-3 polyunsaturated fatty acids, Acta Veterinaria Scandinavica, 2014, 56, 1, 5

    CrossRef

  37. 37
    Jesse D. Riordan, Joseph H. Nadeau, Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse, Mammalian Genome, 2014, 25, 9-10, 473

    CrossRef

  38. 38
    Arun J. Sanyal, Manal F. Abdelmalek, Ayako Suzuki, Oscar W. Cummings, Mario Chojkier, No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial, Gastroenterology, 2014, 147, 2, 377

    CrossRef

  39. 39
    Min Yang, Sitang Gong, Shui Ye, Beth Lyman, Lanlan Geng, Peiyu Chen, Ding-You Li, Non-Alcoholic Fatty Liver Disease in Children: Focus on Nutritional Interventions, Nutrients, 2014, 6, 11, 4691

    CrossRef

  40. 40
    Stefania Basili, Valeria Raparelli, Laura Napoleone, Maria Del Ben, Manuela Merli, Oliviero Riggio, Cristina Nocella, Roberto Carnevale, Pasquale Pignatelli, Francesco Violi, Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis, Digestive and Liver Disease, 2014, 46, 7, 632

    CrossRef

  41. 41
    Minjie Lin, Shuiping Zhao, Li Shen, Danyan Xu, Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition, Drug Safety, 2014, 37, 4, 213

    CrossRef

  42. 42
    Amirhossein Sahebkar, Gerard T. Chew, Gerald F. Watts, Recent advances in pharmacotherapy for hypertriglyceridemia, Progress in Lipid Research, 2014, 56, 47

    CrossRef

  43. You have free access to this content43
    E. B. Mitchel, J. E. Lavine, Review article: the management of paediatric nonalcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 10
  44. You have free access to this content44
    J. Luo, Y. Yang, J. Liu, K. Lu, Z. Tang, P. Liu, L. Liu, Y. Zhu, Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2014, 39, 9
  45. You have free access to this content45
    Z. M. Younossi, M. J. Reyes, A. Mishra, R. Mehta, L. Henry, Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets, Alimentary Pharmacology & Therapeutics, 2014, 39, 1
  46. 46
    Natalia Mazzella, Laura M. Ricciardi, Arianna Mazzotti, Giulio Marchesini, The Role of Medications for the Management of Patients with NAFLD, Clinics in Liver Disease, 2014, 18, 1, 73

    CrossRef

  47. 47
    Jessica Monteiro, Michael Leslie, Mohammed H. Moghadasian, Bianca M. Arendt, Johane P. Allard, David W. L. Ma, The role of n − 6 and n − 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease, Food & Function, 2014, 5, 3, 426

    CrossRef

  48. 48
    Shira Zelber-Sagi, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  49. 49
    Christopher Depner, Kelli Lytle, Sasmita Tripathy, Donald Jump, Liver Metabolism and Fatty Liver Disease, 2014,

    CrossRef

  50. 50
    Li-Ya Wang, Fang Le, Ning Wang, Lei Li, Xiao-Zhen Liu, Ying-Ming Zheng, Hang-Ying Lou, Xiang-Rong Xu, Yun-Long Chen, Xiao-Ming Zhu, He-Feng Huang, Fan Jin, Alteration of fatty acid metabolism in the liver, adipose tissue, and testis of male mice conceived through assisted reproductive technologies: fatty acid metabolism in ART mice, Lipids in Health and Disease, 2013, 12, 1, 5

    CrossRef

  51. 51
    Bashar M. Attar, David H. Van Thiel, Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  52. 52
    John M Casey, William J Banz, Elaine S Krul, Dustie N Butteiger, Daniel A Goldstein, Jeremy E Davis, Effect of stearidonic acid-enriched soybean oil on fatty acid profile and metabolic parameters in lean and obese Zucker rats, Lipids in Health and Disease, 2013, 12, 1, 147

    CrossRef

  53. 53
    Wataru Tomeno, Masato Yoneda, Kento Imajo, Yuji Ogawa, Takaomi Kessoku, Satoru Saito, Yuichiro Eguchi, Atsushi Nakajima, Emerging drugs for non-alcoholic steatohepatitis, Expert Opinion on Emerging Drugs, 2013, 18, 3, 279

    CrossRef

  54. 54
    Satoshi Hirako, Hyoun Ju Kim, Yuzuru Iizuka, Maki Nakasatomi, Akiyo Matsumoto, Fish oil prevents excessive hepatic lipid accumulation without inducing oxidative stress, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2013, 88, 5, 365

    CrossRef

  55. 55
    Tugrul Purnak, Yusuf Yilmaz, Liver disease and malnutrition, Best Practice & Research Clinical Gastroenterology, 2013, 27, 4, 619

    CrossRef

  56. 56
    Anne-Mari Mustonen, Vesa Kärjä, Michael Kilpiö, Raija Tammi, Markku Tammi, Kirsti Rouvinen-Watt, Toivo Halonen, Petteri Nieminen, Manifestations of Fasting-Induced Fatty Liver and Rapid Recovery from Steatosis in Voles Fed Lard or Flaxseed Oil Lipids, Nutrients, 2013, 5, 10, 4211

    CrossRef

  57. 57
    Howard C. Masuoka, Naga Chalasani, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals, Annals of the New York Academy of Sciences, 2013, 1281, 1
  58. 58
    Beth Conlon, Jeannette Beasley, Karin Aebersold, Sunil Jhangiani, Judith Wylie-Rosett, Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD), Nutrients, 2013, 5, 10, 4093

    CrossRef

  59. 59
    Jessica Monteiro, Fatemeh Askarian, Manabu T. Nakamura, Mohammed H. Moghadasian, David W.L. Ma, Oils rich in α-linolenic acid independently protect against characteristics of fatty liver disease in the Δ6-desaturase null mouse1, Canadian Journal of Physiology and Pharmacology, 2013, 91, 6, 469

    CrossRef

  60. 60
    E. Scorletti, C.D. Byrne, Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease, Annual Review of Nutrition, 2013, 33, 1, 231

    CrossRef

  61. 61
    Scott S. Malinowski, Jennifer S. Byrd, Allison M. Bell, Marion R. Wofford, Daniel M. Riche, Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease in Adults, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 2
  62. 62
    Vlad Ratziu, Pharmacological agents for NASH, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 676

    CrossRef

  63. 63
    Maeva Guillaume, Vlad Ratziu, Pharmacological agents for nonalcoholic steatohepatitis, Hepatology International, 2013, 7, S2, 833

    CrossRef

  64. 64
    Anthony Fardet, Jean-Michel Chardigny, Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies, Critical Reviews in Food Science and Nutrition, 2013, 53, 6, 535

    CrossRef

  65. 65
    Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios, Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids, Nutrition Reviews, 2013, 71, 11
  66. 66
    Dawn M. Fedor, Yuriko Adkins, John W. Newman, Bruce E. Mackey, Darshan S. Kelley, The Effect of Docosahexaenoic Acid ont10,c12-Conjugated Linoleic Acid-Induced Changes in Fatty Acid Composition of Mouse Liver, Adipose, and Muscle, Metabolic Syndrome and Related Disorders, 2013, 11, 1, 63

    CrossRef

  67. 67
    Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji, Clinical Nutrition, 2013,

    CrossRef

  68. 68
    Konstantinos Tziomalos, Vasilios G Athyros, Asterios Karagiannis, Advances in Dyslipidemia, 2013,

    CrossRef

  69. 69
    O. W. Kwon, D. W. Jun, S. M. Lee, K. N. Lee, H. L. Lee, O. Y. Lee, B. C. Yoon, H. S. Choi, Carbohydrate but not fat is associated with elevated aminotransferases, Alimentary Pharmacology & Therapeutics, 2012, 35, 9
  70. 70
    Sarah J. Borengasser, R. Scott Rector, Grace M. Uptergrove, E. Matthew Morris, James W. Perfield, Frank W. Booth, Kevin L. Fritsche, Jamal A. Ibdah, John P. Thyfault, Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF Rats, Journal of Nutrition and Metabolism, 2012, 2012, 1

    CrossRef

  71. 71
    Mohammed M. H. Al-Gayyar, Mohamed E. E. Shams, Enaase A. M. E. Barakat, Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease, Pharmaceutical Biology, 2012, 50, 3, 297

    CrossRef

  72. 72
    Dimitrios Papandreou, Zaharoula Karabouta, Athina Pantoleon, Israel Rousso, Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease, Appetite, 2012, 59, 3, 939

    CrossRef

  73. 73
    William Nseir, Julnar Mograbi, Murad Ghali, Lipid-Lowering Agents in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Human Studies, Digestive Diseases and Sciences, 2012, 57, 7, 1773

    CrossRef

  74. 74
    Suzanne E. Mahady, Jacob George, Management of Nonalcoholic Steatohepatitis, Clinics in Liver Disease, 2012, 16, 3, 631

    CrossRef

  75. 75
    Luis A. Videla, Paulina Pettinelli, Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity, PPAR Research, 2012, 2012, 1

    CrossRef

  76. 76
    L. S. Bhatia, N. P. Curzen, P. C. Calder, C. D. Byrne, Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?, European Heart Journal, 2012, 33, 10, 1190

    CrossRef

  77. 77
    Yasar Colak, Ilyas Tuncer, Ebubekir Senates, Oguzhan Ozturk, Levent Doganay, Yusuf Yilmaz, Nonalcoholic Fatty Liver Disease: A Nutritional Approach, Metabolic Syndrome and Related Disorders, 2012, 10, 3, 161

    CrossRef

  78. 78
    Kouichi Miura, Hirohide Ohnishi, Nonalcoholic fatty liver disease: from lipid profile to treatment, Clinical Journal of Gastroenterology, 2012, 5, 5, 313

    CrossRef

  79. 79
    Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji, Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

  80. 80
    Helen M. Parker, Nathan A. Johnson, Catriona A. Burdon, Jeffrey S. Cohn, Helen T. O’Connor, Jacob George, Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis, Journal of Hepatology, 2012, 56, 4, 944

    CrossRef

  81. 81
    M. Elias-Miró, M. B. Jiménez-Castro, M. Mendes-Braz, A. Casillas-Ramírez, C. Peralta, The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury, PPAR Research, 2012, 2012, 1

    CrossRef

  82. 82
    Naga Chalasani, Zobair Younossi, Joel E Lavine, Anna Mae Diehl, Elizabeth M Brunt, Kenneth Cusi, Michael Charlton, Arun J Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, The American Journal of Gastroenterology, 2012, 107, 6, 811

    CrossRef

  83. 83
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology, Gastroenterology, 2012, 142, 7, 1592

    CrossRef

  84. You have free access to this content84
    Naga Chalasani, Zobair Younossi, Joel E. Lavine, Anna Mae Diehl, Elizabeth M. Brunt, Kenneth Cusi, Michael Charlton, Arun J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 2012, 55, 6
  85. 85
    Erin Marie McCarthy, Mary E. Rinella, The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease, Journal of the Academy of Nutrition and Dietetics, 2012, 112, 3, 401

    CrossRef

  86. 86
    Marialena Mouzaki, Johane P. Allard, The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2012, 46, 6, 457

    CrossRef

  87. 87
    Trent Nichols, Advancing Medicine with Food and Nutrients, Second Edition, 2012,

    CrossRef

  88. 88
    Ali A. Mencin, Joel E. Lavine, Advances in Pediatric Nonalcoholic Fatty Liver Disease, Pediatric Clinics of North America, 2011, 58, 6, 1375

    CrossRef

  89. 89
    F. Scaglioni, S. Ciccia, M. Marino, G. Bedogni, S. Bellentani, ASH and NASH, Digestive Diseases, 2011, 29, 2, 202

    CrossRef

  90. 90
    Ashraf Mohammad El-Badry, Jae-Hwi Jang, Ahmed Elsherbiny, Claudio Contaldo, Yinghua Tian, Dimitri A. Raptis, Endre Laczko, Wolfgang Moritz, Rolf Graf, Pierre-Alain Clavien, Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A2, Journal of Hepatology, 2011, 55, 6, 1291

    CrossRef

  91. 91
    Angela M. Zivkovic, Natalie Telis, J. Bruce German, Bruce D. Hammock, Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health, California Agriculture, 2011, 65, 3, 106

    CrossRef

  92. 92
    Satoshi Kajikawa, Kazunori Imada, Takashi Takeuchi, Yutaka Shimizu, Akiko Kawashima, Tsuyoshi Harada, Kiyoshi Mizuguchi, Eicosapentaenoic Acid Attenuates Progression of Hepatic Fibrosis with Inhibition of Reactive Oxygen Species Production in Rats Fed Methionine- and Choline-Deficient Diet, Digestive Diseases and Sciences, 2011, 56, 4, 1065

    CrossRef

  93. 93
    Didier Quilliot, Philip Bohme, Olivier Ziegler, La stéatohépatite non alcoolique. Influence de la nutrition, de la physiopathologie au traitement, Nutrition Clinique et Métabolisme, 2011, 25, 3, 153

    CrossRef

  94. 94
    Anthony Fardet, Jean-François Martin, Jean-Michel Chardigny, Lipotropic capacity of raw plant-based foods: A new index that reflects their lipotrope density profile, Journal of Food Composition and Analysis, 2011, 24, 7, 895

    CrossRef

  95. 95
    Tomonori Kishino, Hiroaki Ohnishi, Kouki Ohtsuka, Satsuki Matsushima, Tsuyoshi Urata, Keiko Watanebe, Yukihisa Honda, Yoshitake Mine, Motoko Matsumoto, Kaori Nishikawa, Hideaki Mori, Shin'ichi Takahashi, Hitoshi Ishida, Takashi Watanabe, Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury, Clinical Chemistry and Laboratory Medicine, 2011, 49, 1

    CrossRef

  96. 96
    Un Ju Jung, Peri N. Millman, Alan R. Tall, Richard J. Deckelbaum, n−3 Fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011, 1811, 9, 491

    CrossRef

  97. 97
    Hendrik A. Marsman, Michal Heger, Jaap J. Kloek, Syert L. Nienhuis, Fiebo J.W. ten Kate, Thomas M. van Gulik, Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats, Digestive and Liver Disease, 2011, 43, 12, 984

    CrossRef

  98. 98
    Suzanne M. Pilkington, Rachel E. B Watson, Anna Nicolaou, Lesley E. Rhodes, Omega-3 polyunsaturated fatty acids: photoprotective macronutrients, Experimental Dermatology, 2011, 20, 7
  99. 99
    Luis Alberto Videla, Ana María Obregón, Paulina Pettinelli, Patología de hígado graso no-alcohólico (HGNA) asociada a obesidad: mecanismos patogénicos, Medwave, 2011, 11, 07

    CrossRef

  100. 100
    Rodrigo Valenzuela, Luis A. Videla, The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity, Food & Function, 2011, 2, 11, 644

    CrossRef

  101. 101
    Anthony Fardet, Jean-François Martin, Jean-Michel Chardigny, Thermal and refining processes, not fermentation, tend to reduce lipotropic capacity of plant-based foods, Food & Function, 2011, 2, 8, 483

    CrossRef

  102. 102
    Giuseppe Astarita, Daniele Piomelli, Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2011, 85, 5, 197

    CrossRef

  103. 103
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  104. 104
    Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini, A position statement on NAFLD/NASH based on the EASL 2009 special conference, Journal of Hepatology, 2010, 53, 2, 372

    CrossRef

  105. 105
    Juan G. Gormaz, Ramón Rodrigo, Luis A. Videla, Megan Beems, Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease, Progress in Lipid Research, 2010, 49, 4, 407

    CrossRef

  106. 106
    Anna Kotronen, Tuulikki Seppänen-Laakso, Jukka Westerbacka, Tuula Kiviluoto, Johanna Arola, Anna-Liisa Ruskeepää, Hannele Yki-Järvinen, Matej Orešič, Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra-abdominal Adipose Tissue, and Serum, Obesity, 2010, 18, 5
  107. 107
    Julia Araya, Ramón Rodrigo, Paulina Pettinelli, A. Verónica Araya, Jaime Poniachik, Luis A. Videla, Decreased Liver Fatty Acid Δ-6 and Δ-5 Desaturase Activity in Obese Patients, Obesity, 2010, 18, 7
  108. 108
    Francesco Sofi, Ilaria Giangrandi, Francesca Cesari, Ilaria Corsani, Rosanna Abbate, Gian Franco Gensini, Alessandro Casini, Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study, International Journal of Food Sciences and Nutrition, 2010, 61, 8, 792

    CrossRef

  109. 109
    Naoki Tanaka, Xiuguo Zhang, Eiko Sugiyama, Hiroyuki Kono, Akira Horiuchi, Takero Nakajima, Hiroki Kanbe, Eiji Tanaka, Frank J. Gonzalez, Toshifumi Aoyama, Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice, Biochemical Pharmacology, 2010, 80, 10, 1601

    CrossRef

  110. 110
    Christopher D Byrne, Fatty liver: Role of inflammation and fatty acid nutrition, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2010, 82, 4-6, 265

    CrossRef

  111. 111
    J.R. van Werven, T.C.M.A. Schreuder, A.J. Nederveen, C. Lavini, P.L.M. Jansen, J. Stoker, Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy, European Journal of Radiology, 2010, 75, 2, e102

    CrossRef

  112. 112
    J Oya, T Nakagami, S Sasaki, S Jimba, K Murakami, T Kasahara, T Wasada, H Sekiguchi, M Hasegawa, Y Endo, Y Iwamoto, Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women, European Journal of Clinical Nutrition, 2010, 64, 10, 1179

    CrossRef

  113. 113
    Luis A. Videla, Liver NF-κB and AP-1 activation and PPAR-α expression are negatively correlated in obese patients: Pro-inflammatory implications, Clinical Nutrition, 2010, 29, 5, 687

    CrossRef

  114. 114
    Sophie C Cazanave, Gregory J Gores, Mechanisms and clinical implications of hepatocyte lipoapoptosis, Clinical Lipidology, 2010, 5, 1, 71

    CrossRef

  115. 115
    Pablo Perez-Martinez, Francisco Perez-Jimenez, Jose Lopez-Miranda, n-3 PUFA and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010, 1801, 3, 362

    CrossRef

  116. 116
    G. Musso, R. Gambino, M. Cassader, Non-alcoholic fatty liver disease from pathogenesis to management: an update, Obesity Reviews, 2010, 11, 6
  117. 117
    Hannele Yki-Järvinen, Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data, Current Opinion in Clinical Nutrition and Metabolic Care, 2010, 13, 6, 709

    CrossRef

  118. 118
    Yavuz Beyazit, Tugrul Purnak, Murat Kekilli, Omega-3 Fatty Acids: A Promising Alternative Treatment Approach for Patients with Nonalcoholic Fatty Liver Disease, Digestive Diseases and Sciences, 2010, 55, 8, 2422

    CrossRef

  119. 119
    S. Kaser, C. F. Ebenbichler, H. Tilg, Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease, International Journal of Clinical Practice, 2010, 64, 7
  120. 120
    Jessica Zúñiga, Francisca Venegas, Marcela Villarreal, Daniel Núñez, Marlene Chandía, Rodrigo Valenzuela, Gladys Tapia, Patricia Varela, Luis A. Videla, Virginia Fernández, Protection againstin vivoliver ischemia-reperfusion injury byn-3long-chain polyunsaturated fatty acids in the rat, Free Radical Research, 2010, 44, 8, 854

    CrossRef

  121. 121
    G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES, Review article: omega-3 fatty acids – a promising novel therapy for non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2010, 31, 7
  122. 122
    G. S. MASTERTON, J. N. PLEVRIS, P. C. HAYES, Review article: omega-3 fatty acids – a promising novel therapy for non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2010, 31, 7
  123. 123
    Jeremy F. L. Cobbold, Quentin M. Anstee, Simon D. Taylor-Robinson, The importance of fatty liver disease in clinical practice, Proceedings of the Nutrition Society, 2010, 69, 04, 518

    CrossRef

  124. 124
    Pierre-Alain Clavien, Christian E. Oberkofler, Dimitri A. Raptis, Kuno Lehmann, Andreas Rickenbacher, Ashraf Mohammad El-Badry, What is critical for liver surgery and partial liver transplantation: Size or quality?, Hepatology, 2010, 52, 2
  125. 125
    Ashraf Mohammad El-Badry, Stefan Breitenstein, Wolfram Jochum, Kay Washington, Valérie Paradis, Laura Rubbia-Brandt, Milo A. Puhan, Ksenija Slankamenac, Rolf Graf, Pierre-Alain Clavien, Assessment of Hepatic Steatosis by Expert Pathologists, Annals of Surgery, 2009, 250, 5, 691

    CrossRef

  126. 126
    Anish A. Patel, Dawn M. Torres, Stephen A. Harrison, Effect of Weight Loss on Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2009, 43, 10, 970

    CrossRef

  127. 127
    Paulina Pettinelli, Talía del Pozo, Julia Araya, Ramón Rodrigo, A. Verónica Araya, Gladys Smok, Attila Csendes, Luis Gutierrez, Jorge Rojas, Owen Korn, Fernando Maluenda, Juan C. Diaz, Guillermo Rencoret, Italo Braghetto, Jaime Castillo, Jaime Poniachik, Luis A. Videla, Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 11, 1080

    CrossRef

  128. 128
    A. Kotronen, T. Seppanen-Laakso, J. Westerbacka, T. Kiviluoto, J. Arola, A.-L. Ruskeepaa, M. Oresic, H. Yki-Jarvinen, Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver, Diabetes, 2009, 58, 1, 203

    CrossRef

  129. 129
    Satoshi Kajikawa, Tsuyoshi Harada, Akiko Kawashima, Kazunori Imada, Kiyoshi Mizuguchi, Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, 80, 4, 229

    CrossRef

  130. 130
    M. A. Edens, F. Kuipers, R. P. Stolk, Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers, Obesity Reviews, 2009, 10, 4
  131. 131
    Vlad Ratziu, Shira Zelber-Sagi, Pharmacologic Therapy of Non-Alcoholic Steatohepatitis, Clinics in Liver Disease, 2009, 13, 4, 667

    CrossRef

  132. 132
    Byounghoon Hwang, Nam Ho Jeoung, Robert A. Harris, Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet, Biochemical Journal, 2009, 423, 2, 243

    CrossRef

  133. 133
    Jonathan Meisel, Mark Puder, Hau Le, Vincent E. De Meijer, Kathleen Gura, Nutrition, Diet Therapy, and the Liver, 2009,

    CrossRef

  134. 134
    Ana Dâmaso, Lian Tock, Aline de Piano, Rajaventhan Srirajaskanthan, Nutrition, Diet Therapy, and the Liver, 2009,

    CrossRef

  135. 135
    Mariangela Allocca, Carlo Selmi, Nutrition, Diet Therapy, and the Liver, 2009,

    CrossRef

  136. 136
    Jacquelyn J. Maher, Pablo Leon, James C. Ryan, Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis, Hepatology, 2008, 48, 2
  137. 137
    Dawn M. Torres, Stephen A. Harrison, Diagnosis and Therapy of Nonalcoholic Steatohepatitis, Gastroenterology, 2008, 134, 6, 1682

    CrossRef

  138. 138
    Ronald P Mensink, Jogchum Plat, Patrick Schrauwen, Diet and nonalcoholic fatty liver disease, Current Opinion in Lipidology, 2008, 19, 1, 25

    CrossRef

  139. 139
    Dawn Fedor, Sher Himmat S. Gill, Yuriko Adkins, Darshan S. Kelley, Dietary Supplementation With Omega-3 Polyunsaturated Fatty Acids, Clinical Nutrition INSIGHT, 2008, 34, 3, 1

    CrossRef

  140. 140
    L. Spadaro, O. Magliocco, D. Spampinato, S. Piro, C. Oliveri, C. Alagona, G. Papa, A.M. Rabuazzo, F. Purrello, Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease, Digestive and Liver Disease, 2008, 40, 3, 194

    CrossRef

  141. 141
    Satoshi Wada, Tomomi Yamazaki, Yukari Kawano, Shinji Miura, Osamu Ezaki, Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice, Journal of Hepatology, 2008, 49, 3, 441

    CrossRef

  142. 142
    Filomena Morisco, Paola Vitaglione, Daniela Amoruso, Barbara Russo, Vincenzo Fogliano, Nicola Caporaso, Foods and liver health, Molecular Aspects of Medicine, 2008, 29, 1-2, 144

    CrossRef

  143. 143
    Naoki Tanaka, Kenji Sano, Akira Horiuchi, Eiji Tanaka, Kendo Kiyosawa, Toshifumi Aoyama, Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis, Journal of Clinical Gastroenterology, 2008, 42, 4, 413

    CrossRef

  144. 144
    Helena Cortez-Pinto, Mariana Machado, Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease, Expert Review of Gastroenterology & Hepatology, 2008, 2, 2, 217

    CrossRef

  145. 145
    N.A. van Herpen, V.B. Schrauwen-Hinderling, Lipid accumulation in non-adipose tissue and lipotoxicity, Physiology & Behavior, 2008, 94, 2, 231

    CrossRef

  146. 146
    Isabelle A Leclercq, Yves Horsmans, Nonalcoholic fatty liver disease: the potential role of nutritional management, Current Opinion in Clinical Nutrition and Metabolic Care, 2008, 11, 6, 766

    CrossRef

  147. 147
    Nathan A. Johnson, David W. Walton, Toos Sachinwalla, Campbell H. Thompson, Kate Smith, Patricia A. Ruell, Stephen R. Stannard, Jacob George, Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders, Hepatology, 2008, 47, 5
  148. 148
    Alexander R Moschen, Herbert Tilg, Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease, Current Opinion in Clinical Nutrition and Metabolic Care, 2008, 11, 5, 620

    CrossRef

  149. 149
    Johane P. Allard, Elaheh Aghdassi, Saira Mohammed, Maitreyi Raman, Ghazal Avand, Bianca M. Arendt, Pegah Jalali, Thileep Kandasamy, Nita Prayitno, Morris Sherman, Maha Guindi, David W.L. Ma, Jenny E. Heathcote, Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study, Journal of Hepatology, 2008, 48, 2, 300

    CrossRef

  150. 150
    Xiong Ma, Jing Hua, Zhiping Li, Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells, Journal of Hepatology, 2008, 49, 5, 821

    CrossRef

  151. 151
    M. K. OH, J. WINN, F. POORDAD, Review article: diagnosis and treatment of non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2008, 28, 5
  152. 152
    Richard H. Moseley, Therapy for Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2008, 42, 4, 332

    CrossRef

  153. 153
    Dawn M. Torres, Stephen A. Harrison, Current treatments in nonalcoholic steatohepatitis, Current Treatment Options in Gastroenterology, 2007, 10, 6, 425

    CrossRef

  154. 154
    Tomomi Yamazaki, Akiko Nakamori, Eriko Sasaki, Satoshi Wada, Osamu Ezaki, Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddy mice, Hepatology, 2007, 46, 6
  155. 155
    Shira Zelber-Sagi, Dorit Nitzan-Kaluski, Rebecca Goldsmith, Muriel Webb, Laurie Blendis, Zamir Halpern, Ran Oren, Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study, Journal of Hepatology, 2007, 47, 5, 711

    CrossRef

  156. 156
    Pascal G. P. Martin, Hervé Guillou, Frédéric Lasserre, Sébastien Déjean, Annaig Lan, Jean-Marc Pascussi, Magali SanCristobal, Philippe Legrand, Philippe Besse, Thierry Pineau, Novel aspects of PPARα-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study, Hepatology, 2007, 45, 3
  157. 157
    Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien, Omega 3 – Omega 6: What is right for the liver?, Journal of Hepatology, 2007, 47, 5, 718

    CrossRef

  158. 158
    Haim Shapiro, Rafael Bruck, Omega-3 May Indirectly Reduce Hepatocyte Triglycerides Through Modulation of Hyperinsulinemia, Cytokines and Adipocytokines, The American Journal of Cardiology, 2007, 99, 1, 146

    CrossRef

  159. 159
    Sang Lee, Kathleen M. Gura, Mark Puder, Omega-3 fatty acids and liver disease, Hepatology, 2007, 45, 4
  160. 160
    Vlad Ratziu, Maria Vispo, Mohamed Tahiri, Luminita Bonyhay, Mercedes de Torres, Carole Bernhardt, Thierry Poynard, Pascal Lebray, Peut-on traiter la stéatohépatite métabolique ?, Gastroentérologie Clinique et Biologique, 2007, 31, 3, 333

    CrossRef

  161. 161
    Maria C. Diakou, Evangelos N. Liberopoulos, Dimitri P. Mikhailidis, Epaminondas V. Tsianos, Andrew K. Burroughs, Moses S. Elisaf, Pharmacological treatment of non-alcoholic steatohepatitis: The current evidence, Scandinavian Journal of Gastroenterology, 2007, 42, 2, 139

    CrossRef

  162. 162
    Giuseppe Calamita, Piero Portincasa, Present and future therapeutic strategies in non-alcoholic fatty liver disease, Expert Opinion on Therapeutic Targets, 2007, 11, 9, 1231

    CrossRef

  163. 163
    J.-L. Schlienger, Quel régime en cas de stéatose hépatique non alcoolique ?, Médecine des Maladies Métaboliques, 2007, 1, 4, 55

    CrossRef

  164. 164
    Gianluca Svegliati-Baroni, Cinzia Candelaresi, Stefania Saccomanno, Gianna Ferretti, Tiziana Bachetti, Marco Marzioni, Samuele De Minicis, Liliana Nobili, Renata Salzano, Alessia Omenetti, Deborah Pacetti, Soeren Sigmund, Antonio Benedetti, Alessandro Casini, A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats, The American Journal of Pathology, 2006, 169, 3, 846

    CrossRef

  165. 165
    Giulio Marchesini, Rebecca Marzocchi, Anna S. Sasdelli, Cristiana Andruccioli, Silvia Di Domizio, Dietary Factors in the Pathogenesis and Care of Patients with Fatty Liver Disease,
  166. 166
    David Q.-H. Wang, Piero Portincasa, Brent A. Neuschwander-Tetri, Steatosis in the Liver, Comprehensive Physiology,
  167. 167
    Fernando Bril, Kwame Ntim, Romina Lomonaco, Kenneth Cusi, Treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH),